Serologic response to hepatitis B vaccination in HIV-Infected patients with isolated positivity for antibodies to hepatitis B core antigen.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 20210647.
- Also identified by DOI 10.1086/651422.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We assessed the safety and immunogenicity of hepatitis B vaccination among 40 human immunodeficiency virus-infected patients with isolated positivity for antibodies to hepatitis B core antigen. No baseline factors were found to be predictive of an anamnestic response, which occurred in 32.5% of the patients. The overall response rate among patients without an anamnestic response was 74.0% after 3-6 vaccine doses.
Medical subject headings
- HIV Infections
- Hepatitis B Antibodies
- Hepatitis B Core Antigens
- Hepatitis B Vaccines